The changes to IR35 are due be introduced in April 2021 and are set to have a large impact on the UK contracting market. The changes were initially scheduled to take place in March 2020 but due to the global pandemic they were put on hold. The delay has provided contractors and companies extra time to ensure they were prepared for the change in how a contractor’s IR35 status will be determined. Companies were already preparing for the initial April 2020 deadline and through working with numerous life sciences companies, we have been able to see a range of approaches. As 2021 quickly approaches and companies need to revisit their IR35 preparations, we want to share some of the key lessons we learnt from 2020. What are the changes? The legislation itself is not changing, however, the parties responsible for assessing a contractor’s status and deducting/reporting the tax has been revised. Under the current legislation: Where a contractor is operating via their own personal Service Company, they are responsible for making the Status Determination and confirming if they are in or outside of scope of the current IR35 rules. The liability sits with the contractor. Under the revised legislation: The client will be responsible for assessing and providing the Status Determination on whether the contractor falls within scope of IR35. The liability would shift to the client who will be responsible for communicating this decision down the supply chain until it reaches the “Fee Payer” i.e. the entity paying the PSC, which is usually the agency. Once a status determination has been received by the Fee Payer, they are responsible for applying this decision. Where the assignment is out of scope, the Fee Payer will pay the PSC gross and the contractor will be responsible for paying the correct tax to HMRC. There the assignment is in scope the Fee Payer will be responsible for: Deducting PAYE and NICs and paying the PSC the NET valuePaying the Employers NICsReporting the deductions made via Real-Time Information Lessons learntHaving worked with a broad range of biotechnology, pharmaceutical and medical devices companies and CROs throughout the preparations for IR35 in late 2019/early 2020, we had a unique insight into the various methods, successes and pitfalls in the planning. These are some of the core lessons learnt from 2020: A Team Approach Many companies had delegated one core lead for their IR35 preparations, but the ones that saw a more successful preparation process where those that had multiple internal stakeholders involved. “It’s definitely not too late to start making changes and to start implementing what has to be done and one of those key things is undoubtedly ensuring that you have a robust IR35 project team internally, where everyone within that project team understands what their responsibilities are. In terms of the project team, we found out very quickly that it’s too much for one individual to take on themselves…”Elliot Tiffin - Vice President of Global Contract Services at Hobson Prior Communication was a core influencer in determining successful preparation. Knowing how many contractors will be impacted, contacting each section of the supply chain and ensuring all parties were aware of their responsibilities and decisions being made should not be underestimated. It was the companies that were willing to invest time and resources to these processes and engage their contractors, consultants and their peers in the market. “From the approaches that were good from our clients and the industry, in particular, were those that were open and transparent and shared not only their concerns with us, but with each other, whether it be forums or conferences – those that were open to their concerns and then their solutions definitely fared better than those that didn’t.”Elliot Tiffin - Vice President of Global Contract Services at Hobson Prior Communication channels crossed With many variable unknown and several businesses at different stages of their preparations, there was a lot of rumour regarding how contractors may be impacted in comparison to their peers within the life sciences contracting market. As is the nature of contracting, there is a level of separation with the end client they are providing services for and contractors, which led to contractors questioning their recruitment agencies, different stakeholders within the business as well as their peers to try and find answers. Without a clear line of communication, this caused problems, as described by Interim Biometrics Team Lead, Mike Masoomi: “Lots of contractors are used to liaising directly with their consultant or their agency that they go through. Others have a more direct line of communication with their line manager or in some cases other stakeholders in the company that they’re contracting with."And what I experienced last year is that a lot of contractors are having half of their conversations internally with the client that there providing services to and the other half with us and that causes a lot of issues and what we need to make sure in 2021 one is that the agency the end client and the contractor all set a clear channel of communication so we can all reach the same objective and that is that all parties are happy and well informed.”Michael Masoomi - Team Lead for Interim Biometrics Recruitment at Hobson Prior This lack of consistent communication ultimately led to frustrated contractors, who were unclear if they were now in or out of scope, how this would impact their income and livelihoods, as well as how and when they would receive this information. This was particularly frustrating as more companies revealed their plans and contractors engaged within the market were receiving mixed messages from their industry peers. Blanket statements cost more than they saved The biggest area of contention we saw in the IR35 preparations in 2020, was how companies dealt with determining the status of their contractors. In order to save time, some companies decided to use a blanket approach of defining all their contractors as in scope, however, as we witnessed first-hand, this often caused more problems than it resolved. “With the disputes process, one thing that we did see and that we’ve learnt from the process last year, was that the organisations that made blanket determinations actually received more disputes than any other that we saw so retrospectively the idea of maybe saving time, worked as a hindrance and actually cost them time net in the process when you look at it as an overall.”Elliot Tiffin - Vice President of Global Contract Services at Hobson Prior We saw more disputes regarding status determination from contractors working with companies that had used this blanket approach. Whilst this was a helpful test for the 45-day review process, the time and resources required to deal with the influx of unexpected appeals from contractors challenged the initial reasoning behind taking a blanket statement approach. As well as an increase in disputes, there were other impacts to this method of determining all contractors as in scope of IR35. Reputational impact Another unexpected backlash from companies that took a blanket approach for determining contractor status under IR35 was the impact this had on their reputation across the UK life sciences contracting market. “The organisations that made blanket determination […] actually started to deter candidates from applying to contract projects there as they wanted to ensure that if they did have the possibility of operating outside of the legislation, then they at course could.” Many contractors we worked with were concerned that the determination process was being transferred from their control, so it is unsurprising that there was frustration when they were not being included in the determination process. “What I found most interesting was that it wasn’t just contractors that disagreed with the determination, it was actually contractors that didn’t feel listened too or valued and that was the biggest reason for them looking elsewhere.”Michael Masoomi - Team Lead for Interim Biometrics Recruitment at Hobson Prior There are numerous factors that can impact a status determination position and with contractors’ payment on the line, unclear communication and neglect complicated many previously amicable working relationships. Opportunity to impress Conversely to the above, Hobson Prior found that the companies that engaged their contractors throughout the process and ensured clear and timely information raised their profile within the industry. “Those organisations and those that we partnered with that were really open and transparent to help and that consulted with their contractors on a one-on-one basis actually became hubs for talent. People that were in the industry recognised those organisations as ones that did treat IR35 with the seriousness that it deserves and then they wanted to work for these companies.”Elliot Tiffin - Vice President of Global Contract Services at Hobson Prior With a lot of uncertainty and rumours across the life sciences market, organisations that could provide an organised process and engaged contractors were more appealing and many contractors we worked with were actively seeking opportunities at companies which has a robust IR35 plan in place. Adapting for 2021 The core lessons we’ve seen from the 2020 deadline preparations revolve around one core aspect of the changes to IR35: making status determinations. From this, the advice we’ve been emphasising with our life sciences clients with contractors in the UK is: Ensure your IR35 team has the resources and support neededEstablish transparent communication channels for contractorsEngage contractors throughout the process, adopting a case-by-case approach if possibleEmphasise your understanding and awareness of the impacts to contractors and demonstrate this support with clear guidance and timely updates Of course, collecting all contractors and exploring each of their status factors on a case-by-case status is not to be underestimated, which is why Hobson Prior has developed a Status Determination Tool. This tool allows organisations to determine status and utilise IR35 experts to ensure all factors are considered when determining whether a contractor falls in or out of scope of IR35. Backed by a specialist, award-winning team, the tool provides more than an algorithm and allows our clients to provide contractors with timely and accurate determinations, which in turn promotes better communication and more support in their preparations for April 2021 See how Hobson Prior’s IR35 status determination tool can help life sciences companies best prepare for changes to IR35 by contact our team at IR35@hobsonprior.com
The second interview can sometimes be the final stage in the interview process. They are often conducted by line managers and decision makers, so it is important that the right questions are asked. The first interview should have clarified enough soft skills and experience to warrant shortlisting the candidate to progress to this stage. Second interviews usually involve more targeted and specific questions, relating to hard skills and how the candidate would fit not only in the vacancy, but also the dynamics of the team and company they are joining. Questions will vary based on the role, the candidate and whoever is conducting the interview, but there is a general pattern that follows second interviews. Questions will usually fall into one of the following categories: Anything from the earlier stages that needs clarifying At this stage, the candidate has impressed enough with a CV, a cover letter, an initial telephone call and/or a face-to-face interview. There may still be some aspects from these stages that need confirmation, particularly if the second interviewer wasn’t present at the first one. Some questions you may wish to consider include: “In your last interview/on your CV, you mentioned XXXX, could you tell me a bit more about that?” If you are addressing something from the past, providing context will help the candidate understand what it is you need clarification on and not repeat what you already know. “Do you want to revisit anything from the first interview?” Framing the question like this gives the candidate the opportunity to clarify themselves or highlight something they didn’t get to in the first interview. This is a useful icebreaker and can relieve some tension for the candidate to revisit something they’ve been worried about from an earlier stage of the process. “Do you have any questions about the business or the role since your first interview?” In a multi-stage interview process, the candidate may be involved in other interview processes or have received new information since the last conversation. This is a good way to break the ice and ensure they are still confident your company is a good match for them. Questions specific to the role With the general soft skills being the focal point of the first interview, a second interview focuses more on the specific benefits a candidate will bring and how they will add value to the business through the roles. This is particularly important in the niche skills and understanding required within different aspects of the life sciences industry. “What are the first three things you’d look to change/implement if you started tomorrow?” This is a useful way to see the value the candidate will bring to the business and their understanding of the role. how much the candidate understands about your business. They may not know too much about the inner workings of your business, but you’ll be able to see their thought process, priorities and might even get some useful feedback on your existing processes.” “What should our company be doing?” (alternatively, what are our competitors doing that we aren’t?) This highlights what the candidate knows about your market, the competitors and what industry trends are transforming the market to keep businesses competitive. Are they aware of trends like AI, recently released research or new regulations that would impact the role they are interviewing for? Also, you might get some good insight to evolve your business too. N.B. – Often, candidates can feel tripped up by questions about change. While it may be a sign of leadership for them to confidently highlight issues, some may need encouraging if they are afraid of bad mouthing the processes of their potential new employer. “What type of impact did you make at your last role?” This is a useful way to see if they are results, people or process driven. Keep an eye out for if they respond with stats and numbers for their results, talk about new efficient processes or if they focus on managing teams and working with their colleagues. This will give you insight into what they value and how they measure their success. “We are currently implementing XYZ, do you have experience with this/how would you tackle this?” Using active scenarios gives a useful insight in how the candidate would take on the challenges your business is currently facing. Listening to their thought process will enable you to evaluate the candidates based on actual situations they’ll be up against and may also give you some good insight into the issues impacting your teams too. “What do you know about our product and services? Have you worked on something similar before?” Similar to the above question; how much research has the candidate done into your business? More importantly, how much experience do they have in the area of the industry that your company will be focusing on? These live examples are good ways to simulate conversations you will be having with them as a future employee. “Tell me about a time a project’s deadline changed and you had to adapt” Real world examples are useful ways to see how a potential future employee deals with certain scenarios. Pick a stress point that may occur in their role to evaluate their response to unexpected or stressful situations. Personality and culture compatibility The second interview is usually conducted by someone who will be working in close relation to the new employee so this is a great opportunity to get a feel for how they would be to work with. Successful hires rely on the candidate being compatible with the team and company culture they will be joining. “What is your preferred management style?” As well as highlighting their personal management style and experience, this question will help you understand how compatible the candidate may be with your current leadership structures and review culture. “How would you describe yourself in one sentence? How would your friends describe you?” It’s a staple interview question. Asking how others would describe them may lead to some interesting insights about their personality. “What do you get up to outside of work?” A staple interview question – a great icebreaker and allows you to hear more about the person behind the professional. If you have similar interests, this can relieve a lot of tension in the interview process. “In your previous role, did you work more as a team or on an individual basis?” Asking if they prefer to work as a team or individually will likely result in the answer “I work well in both”. Asking about their previous experiences will give a better indication of their preferred way of working and how they talk about their previous teams. Expectations and logistics Depending on how many stages are left in the interview process, the second interview will give you a good gauge on your final hiring decision. These questions are key to ensure that the ideal candidate is not only able to accept a potential offer, but also what expectations they may have from working with you as an employer. “How long is your notice period?” A very simple question that confirms the earliest start date and if the candidate has any obligations or leave that may impact this. “Just want to confirm; do you know what salary this role was advertised with?” Asking about salaries in interview is a divisive topic. Some interviewers will ask upfront, others may prefer to briefly cover the topic and discuss in detail at offer stage. It is important to understand the candidate’s expectations as this may impact your offer. “Have you looked into the logistics of relocating/commuting to * LOCATION*?” Roles that require relocation will likely have been discussed in the very early stages. This question highlights both how seriously the candidate has researched the required move and encourages conversation around any concerns. “I know you’ve mentioned you’re ok with the amount of travel involved in this role, did you have any questions about this?” Questions about travel will likely have already taken place if it is core to the role. This question confirms the candidate’s ability to travel and invites any concerns or negotiations they may have that may influence your decision. Questions that encourage their input It is very easy forget that it is not just the interviewer assessing the candidate, the candidate is also determining if they want to join your company too. Ensuring they have a chance to ask questions and showing awareness of their decision will give them a good opportunity to ensure they are excited to potentially join your team and give you the chance to alleviate any concerns they may have. “What question should I have asked you, but haven’t?” May seem like a trick question, but this is a great way to encourage the candidate to highlight a key point they want you to know that didn’t come up already. Give the candidate a chance to sell themselves. “Is there anything from your current/previous companies that you think we could benefit introducing here?” Industry insight is key to keeping ahead of the game. Not only will this highlight more evidence of how the candidate operated in their previous employment, it may also give you some ideas that can improve your business operations. “Is there anything about the role or company that concerns/worries you?” A simple question, but key to ensuring both you and the candidate leave the interview with the information you need to make an informed decision. This gives you the opportunity to clarify any determining factors or highlight any points that may need to be negotiated before a potential offer. “Do you know much about the culture here?” This is a leading question to set you up into your sales pitch for the company and the role. It is important that you sell the opportunity, benefits and culture. N.B. Remember, great candidates will be in high demand with other job offers, so it is important to highlight the benefits of your company, particularly in the competitive recruitment field of life sciences. Looking to hire life sciences professionals?For more information on our recruitment solutions for interim and permanent vacancies, you can contact our dedicated client services team here, or upload your job description directly.
The life sciences industry relies upon the talents of often niche specialisms, where the number of qualified and experienced candidates can be limited. With a high demand for rare and specialised professionals, it is easy to get to know a lot of the names and faces within some sectors. As an interviewer, you need to ensure you’re conducting fair and unbiased interviews not only hire the best candidates for the job, but also to avoid breaching employment laws. However, this can be become more complex when you have an existing knowledge or awareness of the candidates. Firstly, how do you know the candidate? We meet people in lots of ways within the industry. It is this level of relationship that will ultimately determine how best to address the interview: Networking/Professionally People you meet at industry events, through a company collaboration or perhaps they’re a respected name in the field, won’t necessarily create a conflict of interests. That said, depending on the closeness of your professional relationship, any prior relationship could invite some biases, so it’s important to remain consciously impartial. Previous employer/employee Having experience working with the candidate before will give you valuable insight into their performance, but may also complicate the interview process, as it will be more difficult to remain impartial. Family or friend This relationship is likely the most problematic for an interviewer. Whilst it is certainly possible to be impartial, this may be considered a conflict of interests and could lead to accusations of nepotism or bias. It’s important to follow procedures to protect yourself in this scenario. Internal promotion Perhaps someone from your team is going for a management role or someone from elsewhere in the business is looking to join your team. Depending on your close working relationship, you may find complications in remaining impartial, impacting the fairness of the process for you and your colleague. Balancing the needs of the company, your responsibility as the interviewer and your connection to the person being interviewed can be a tenuous task. Here are some core considerations for how to interview someone that you know within life sciences: 1. Inform your HR team It is best practice to tell your HR team if you are planning to interview a candidate that you have previous connections with. Even what you may consider to be an inconsequential connection can have ramifications, so it is best to protect yourself and ensure you have followed internal procedures. Your HR teams will have a greater knowledge surrounding legal and ethical issues you may not be aware of and will protect you from potential conflicts of interest. Be honest about how you know the candidate and the extent of your relationship with them. 2. Assess whether your involvement is needed How important is it that you conduct the interview? Is there someone else who could take the interview on your behalf? Even if you know you’d be fully professional, it may be easier to defer to colleague and avoid the potential pressures and awkwardness by not being involved. If you do choose to conduct the interview, ensure you are with a colleague and a HR representative if possible. This will protect you and your friends from breaching company policy, as well as guarantee there is an impartial second opinion. It is also worth considering the interviewees thoughts; interviews are stressful enough without the potential pitfalls of knowing your interviewer. Asking if they would be comfortable to be interviewed by you or offering an alternative interviewer could reduce some of this stress. 3. Establish boundaries early Addressing the issue head on will be the quickest and most effective way to clarify the process and dispel any concerns about your involvement, as well as make clear that you will remain professionally impartial. Give a clear explanation on:How you will conduct the interviewHow they will be assessedWho will be involved in the decision-makingHow your existing relationship will (or rather will not) impact the proceedingsThe post-interview process and that you will not be able to influence the outcome Be honest and upfront about your relationship with them and address the elephant in the room. Perhaps give them an alternative interviewer option if it is a friend or an existing colleague. This should relieve tension and set the tone for an impartial and hopefully positive experience for you both. 4. Examine your biases and ethical dilemmaPrepare your response to scenarios before going into the interview. How will you react if they keep bringing up your relationship to them or if they reference personal issues you have a connection to? Highlight areas where your relationship with the candidate could put you in an ethical quandary. For example, if you know the candidate is underselling their skills or not using an example that would help their cause, would you raise this? Would it be unfair to say something on their behalf or to lead the questioning to give them an advantage? Conversely, what if you know them to always be late to social events outside of work, could that create an unfair bias against their professional performance? What if they say something you believe to be untrue? Would you call them out? Could it be your unconscious bias? A useful question to ask yourself to avoid bias is “would you ask this to another candidate?”. A second opinion is always useful to protect your and your friend’s interests. You can defer to them to help you avoid these ethical issues. 5. Evidence over experienceA sure-fire way to protect yourself from any accusation or bias based on assumption from your existing relationship, is to ensure that you have evidence for anything you inherently believe about the candidate. You may know the interviewee has exceptional leadership qualities from working together previously or from how they’ve lead teams outside of a working environment. However, without tangible evidence of this in the interview, you open yourself to criticism on your judgement. Whilst it would be unethical to ask leading questions, the responses they give will be more valuable to the interview assessment. 6. Prepare for the conclusionOne of the pitfalls of interviewing someone you know, is the inevitable questioning of the result. Having established boundaries early on, you should be in a good position, but it is useful to have responses ready. If the candidate is unsuccessful, there may be impacts to your relationship outside of work, or even a complaint about your involvement. Be sure to communicate the decision process with your friend and be transparent about your involvement in any decision-making processes. If the person you know is successful, you may have colleagues or other interviewees question the legitimacy or fairness of your interview. Even if you’ve followed all the procedures or even had a HR representative take over the process. Address concerns of your teams ahead of time and create a positive narrative about the new employee. Keep an open door to discuss any concerns that come up and keep an eye out for how the team dynamics are affected. Ultimately, the life sciences industry is fuelled by networking and collaboration. Having trusted and proven professionals on your team is a bonus and, although there may be some ethical issues to be aware of, having a previous relationship with people joining your team can be a huge advantage to productivity and success. Provided you keep an impartial position and follow procedures, interviewing someone you know can be no different than conducting an interview with a complete stranger. Looking to hire life sciences professionals?For more information on our recruitment solutions for interim and permanent vacancies, you can contact our dedicated client services team here, or upload your job description directly.
Switzerland is one of the most popular places for a pharmaceutical company to establish a new site. Global industry leading companies including Roche, Novartis, Merck and Celgene have a large presence within Switzerland and there is continued interest from international biotech and pharma companies, particularly from the US, to open new sites within the country. Over 40 new biotechs and pharma companies established themselves in there in 2019, so why are so many pharmaceutical companies in Switzerland? Why are European pharma companies concentrated in Switzerland? Switzerland’s relationship within Europe Over a third of Swiss exports come from the pharmaceutical and life sciences industry and the territory has established itself as a leading hub for life sciences development within Europe. With over 250 pharmaceutical and biotechnology companies based across Basel, Zurich, Geneva and other core cities in Switzerland, there is already a proven and well-resourced access to talent, resources, funding and clinical development within the country. Similarly, being geographically close to other leading life sciences hubs within Germany, France and Italy provides Switzerland a very beneficial position to expand a life sciences business. Switzerland and the EU and EMA Switzerland is not a member of the EU or the EEA (European Economic Area), but maintains a confidentiality agreement with the European Commission and European Medicines Agency (EMA) through the Swiss Agency for Therapeutic Products (Swissmedic). Similarly, the sovereign state maintains a strong connection to the European Union with a mutual recognition agreement (MRA) for good manufacturing practice (GMP) compliance, as well as strong ties to the FDA. This unique political and commercial position can be advantageous for pharmaceutical companies to have a presence in this booming market that has more financial and political freedom, whilst ensuring strong connections to the EMA and FDA global markets. Top life sciences talent from Switzerland A core consideration for any site selection is ease of accessibility to top talent within the industry; ultimately, it is a strong workforce that drives success in pharma. Attraction and retention of talented professionals relies on the appeal of the country and its cities, the quality of life and understanding of local customs and employment laws. Whilst it is difficult to quantify analysis for employee potential and happiness in their environment, Switzerland ranks highly across numerous studies in workforce satisfaction and quality of life. Switzerland and access to talent Switzerland has consistently ranked highly in the Global Talent Competitiveness Index (GTCI), which measures and ranks countries based on their ability to grow, attract and retain talent. Switzerland was ranked first place in the GTCI 2020, with notably high rankings in employee retention, enabling employees’ development and encouraging personal growth. With a particular focus on how AI and adoption of technology have impacted the index in 2020, Switzerland’s high ranking demonstrates a promising consideration of innovation alongside talent attraction and business development Similarly, the country ranks highly for many aspects of workforce skills in the World Economic Forum Global Competitiveness report 2019, with 1st place rankings in extent of staff training, quality of vocational training and skillsets of graduates. Switzerland is also home to 4 out of 100 of the Times Higher Education top 100 universities worldwide, with 7 in the top 200 universities, promoting Switzerland’s reputation for education and research. Strong performance in these areas highlights the promising growth Switzerland has in attracting top talent internationally, as well as producing skilled workers within its education system and employee development. Switzerland and quality of life for employees Switzerland scores highly in employee retention on the GTCI 2020, suggesting a satisfactory lifestyle provided for potential employees. This is further supported by Zurich’s position as 2nd, Geneva as 9th and Basel as 10th globally on the Mercer Quality of Living Index 2020, which reviews quality of living standards in line with typical compensation packages. The combination of all these factors, alongside the proximity to other leading life sciences hubs in Germany and France, suggest Switzerland can be a highly beneficial place for skilled professionals to establish their career across biotechnology and pharma, enabling Swiss based pharmaceutical companies access to talented individuals, at a local level, across a range of specialist fields. “Practically all the specialist life sciences candidates we work with are aware of Switzerland’s appeal within the industry. There is no shortage of talented professionals already based or looking to locate to the vicinity so there is often a surplus of viable candidates.” Matthew Vickers, Principal Consultant for Swiss Clinical recruitment at Hobson Prior. “In fact, it is often more difficult for the companies we work with to compete for the attention of this talent, particularly if they don’t know the swiss recruitment system.” Switzerland’s investment in R&D With biotechnology and pharma making up 40% of Swiss exports, Switzerland has the largest export surplus of pharmaceutical products worldwide, producing 88.4 CHF billion in pharmaceutical industry exports in 2019. It is no surprise that Switzerland invests heavily in its research and development schemes to ensure continued growth and innovation. Around 7,000,000,000 CHF was invested into R&D from Swiss pharma companies in 2018, with continued investment and innovation across the pharma and biotech spaces within Switzerland. This led to the development of multiple new start-ups as Switzerland continues to continue to build its life sciences industry. As a core industry, the country is very supportive of its innovators. Switzerland and innovation Switzerland ranked number 1 against EU countries on the in European Innovation Scoreboard 2020, which assesses the relative strengths and weaknesses of national innovation systems within the EU and neighbouring countries. With Switzerland globally renowned for life sciences innovation, the pharma industry is likely to have contributed significantly to this. For life sciences, Switzerland’s commitment to funding innovative ideas provides a great advantage for pharma development. The registration process for obtaining a license for a new pharmaceutical product from the Swiss Agency for Therapeutic Products is one of the fastest in the world and with one of the most sophisticated healthcare systems, it lends itself to efficient pharmaceutical development and clinical testing. With leading biotechs specialising in new technological advancements such as cell and gene therapy, CRISPR and AI integration across the life sciences, the country’s influence in life sciences is visible on a global scale. With a landscape centred on innovation and scientific development, many pharma companies enjoy the benefits of being based there. Switzerland and future stability Through investment in innovation, Switzerland ranks highly across core areas of future development and readiness for changes and advancements within the life sciences industry and across the global business outlook: 1st for change readiness - 20191st for growth promise indicators - 2019 1st for economic freedom in Europe - 20202nd for global resilience - 20203rd for world competitiveness - 2020 Whilst the future is never fully certain, with strong investment and dedication to promoting its life sciences, Switzerland appears to be at the height of pharmaceutical development and with no plans to slow down. Switzerland as an international investment Overall, there are various reasons impacting a pharmaceutical company’s decision for a site location and Switzerland has established itself as a proven global leader in many of these aspects, including talent attraction, investment into innovation and pharmaceutical success. With a large focus on the life sciences and pharma as a core export, it is unsurprising to see so many talented professionals - educated within Switzerland or living locally - and numerous start-up labs and biotech research teams establishing themselves across the country. It is also unsurprising that many growing companies in the pharmaceutical industry who are looking to expand internationally, choose Switzerland as the location for their sites including Hobson Prior, who have a team based in Basel. It is worth noting that, as with any international expansion, the customs, expectations and processes for recruitment within Switzerland can vary significantly.“We see particularly with US pharma companies looking to build teams in Switzerland, they can come across difficulties with time differences and slight differences in processes that makes it difficult to secure top talent in a competitive market.“With so much competition for strong candidates, we help them promote their career opportunities and navigate the local nuances of the typical Swiss recruitment process”.James Inwood – Client Services Manager at Hobson Prior For more information on hiring life sciences professionals in Switzerland as part of an international expansion, you can contact our Swiss recruitment team, or read our case study following how a US company launches its Swiss office despite the time differences and different hiring culture.
View Press Release Hobson Prior obtient une Licence de Travail SECO pour le Recrutement Intérimaire Suisse Hobson Prior est heureux d'avoir obtenu une licence de travail SECO pour le recrutement intérimaire. Cela leur permettra de fournir à l'industrie Suisse de sciences de la vie des solutions de recrutement intérimaire, sans avoir besoin des sociétés de gestion tiers. Détenant déjà une licence de recrutement SECO pour des postes de durée indeterminés, Hobson Prior sera en mesure de fournir des solutions de recrutement complètes et de soutenir à l’échelle plus grand des candidats pour des entreprises des sciences de la vie et des demandeurs d'emploi en Suisse. Après avoir récemment déménagé son bureau en Suisse de Lucerne à Bâle en 2019, Hobson Prior a plus de 10 ans d'expérience direct avec des entreprises basées en Suisse, ainsi qu'avec des entreprises souhaitant s'implanter en Suisse, avec leurs besoins d'embauche. «En fournissant directement des solutions d'emploi aux travailleurs temporaires, nos clients auront un processus de contact plus simple pour leur personnel intérimaire», souligne Patrick Forster, Directeur Général de Hobson Prior. «La Suisse est un carrefour cruciale sur le marché mondial des sciences de la vie et en tant que l'un des rares recruteurs des spécialistes axés sur les sciences de la vie. Nous sommes ravis d’offrir des solutions de recrutement encore mieux à nos clients et un meilleur soutien de notre société basée en Suisse». Reconnue comme un leader mondial de la compétitivité des talents, de l'innovation et de la sélection des sites par le KPMG, la Suisse est l'un des principaux foyers de biotechnologie, des dispositifs médicaux, de nanotechnologie et des produits pharmaceutiques. «Nous avons une équipe dédiée et spécialisée dans des services de recrutement en sciences de la vie en Suisse, couvrant divers aspects du secteur, y compris des affaires réglementaires, des opérations cliniques, la biométrie et des opérations techniques», ajoute James Inwood, Directeur Européen des Services à la Clientèle. «Nos consultants connaissent bien le marché, les coutumes et les processus de recrutement en Suisse. Avec des consultants en recrutement basés dans notre bureau à Bâle, nous pourrions fournir du soutien dédié, non seulement à nos clients, mais aussi aux candidats et aux entreprises qui souhaitent se développer sur les marchés biotechnologies et pharmaceutiques Suisses.» «La Suisse acceuille de nombreuses entreprises innovantes et cette nouvelle licence nous permettre de les connecter à notre vaste réseau de professionnels talentueux des sciences de la vie à distance de leurs bureaux Suisses et même d'aider à la relocalisation pour ceux qui souhaitent de déménager en Suisse.» La Suisse acceuille déjà des grandes sociétés pharmaceutiques et des innovateurs en biotechnologie; alors il n'est pas étonnant qu'il y ait eu une augmentation des créneaux de démarrage d'entreprises tirées d'endroits, par exemple le marché américain, pour faire de la Suisse un carrefour de développement et de livraison des sciences de la vie dans le monde. En tant que leader expérimenté sur le marché Suisse de recrutement dans le domaine des sciences de la vie Hobson Prior fournit, depuis plus de 12 ans en Suisse, des services exceptionnels de recherche et de sélection aux leaders mondiaux et aux entreprises à venir. Cette nouvelle licence leur permettra de continuer à soutenir l'effort impressionant des sociétés pharmaceutiques, biotechnologies et de la technologie médicale grâce aux services de recrutement d’experts. Pour plus d'informations sur la licence SECO de Hobson Prior, ou sur des solutions de recrutement disponsible en Suisse, veuillez contacter notre équipe: E-Mail: email@example.comTéléphone: +41 (0) 615880991
View Press Release Vorläufige SECO Genehmigung für die Schweize Rekrutierung Hobson Prior freut sich, sich für eine SECO Arbeitsgenehmigung für die vorläufige Einstellung berechtigt zu haben. Auf diese Weise darf die Firma der Schweizer Biowissenschaftsbranche vorläufige Rekrutierungslösungen anbieten, ohne dass Lohn- und Gehaltsabrechnungsunternehmen von Drittanbietern erforderlich sind. Hobson Prior verfügt bereits über eine SECO Rekrutierungsgenehmigung für unbefristete Stellen und kann jetzt Volldienst Rekrutierungslösungen und eine breitere Unterstützung für Kandidaten für Life Science Unternehmen und Arbeitssuchende in der Schweiz anbieten. Nachdem Hobson Prior kürzlich sein in der Schweiz ansässiges Büro in 2019 von Luzern nach Basel verlegt hat, verfügt er über mehr als 10 Jahre Erfahrung in der direkten Zusammenarbeit mit in der Schweiz ansässigen Unternehmen sowie mit Unternehmen, die in der Schweiz starten möchten. „Durch die direkte Bereitstellung von Lösungen für Leiharbeitnehmer haben unsere Kunden einen einfacheren Einzelkontaktprozess für ihre kurzfristige Mitarbeiter“ kommentiert Patrick Forster, Geschäftsführer vom Hobson Prior. „Der Schweiz ist ein wichtiger Knotenpunkt auf dem globalen Markt für Biowissenschaften. Als einer der wenigen auf Biowissenschaften spezialisierten Personalvermittler freuen wir uns, unseren Kunden noch bessere Rekrutierungslösungen anzubieten und unsere, in der Schweiz ansässigen, Mitarbeiter besser unterstützen zu können“. Der Schweiz ist vom KPMG als Nummer eins für globale Wettbewerbsfähigkeit, Innovation, und Standortauswahl anerkannt und gilt als eines der führenden Unternehmen für Biotechnologie, Medizinprodukte, Nanotechnologie und Pharma. „Wir haben ein engagiertes Team, das sich auf Rekrutierungsdienste für Schweizer Biowissenschaften spezialisiert hat und verschiedene Aspekte des Sektors abdeckt, einschließlich regulatorischer Angelegenheiten, klinischer Operationen, sowie biometrischer und technischer Operationen“, fügt James Inwood, European Client Services Manager, hinzu. „Diese Berater kennen den Schweizer Markt, die Zoll- und Rekrutierungsprozesse. Mit Personalberatern in unserem Schweizen Büro können wir nicht nur unsere Schweizer Kunden, sondern auch Kandidaten und Unternehmen, die in den Schweizer Biotech- und Pharmamarkt expandieren möchten, unterstützen.“ „In der Schweiz sind viele bahnbrechende Unternehmen ansässig. Mit dieser neuer Genehmigung können wir sie mit unserem umfangreichen Netzwerk talentierter Biowissenschaftler in Pendelentfernung zu ihren Schweizer Büros verbinden und sogar bei der Unterstützung von Umzügen für diejenigen helfen, die in die Schweiz ziehen möchten.“ In der Schweiz sind bereits große Pharmaunternehmen und Biotechnologie-Innovatoren ansässig. Deshalb ist es eher klar, dass die Zahl der Nischen-Start-up-Unternehmen, die von Orten wie von den US-Markt vertrieben werden, zugenommen hat um die Schweiz zu einem führenden Zentrum für die Entwicklung und Bereitstellung globaler Biowissenschaften zu machen. Als erfahrene Führungspersönlichkeit auf dem Schweizer Rekrutierungsmarkt für Biowissenschaften bietet Hobson Prior seit über 12 Jahren außergewöhnliche Führungs- und Auswahlunterstützung für weltweit führende Unternehmen und aufstrebende Unternehmen in der Schweiz an. Mit dieser neuer Genehmigung kann die Firma weiterhin die bahnbrechenden Bemühungen von Pharma-, Biotech-, und Medizintechnikunternehmen in der Schweiz durch Expertenrekrutierungsdienste unterstützen. Für weitere Information über die SECO Genehmigung, oder ueber die Schweizer Rekrutierungslösungen, die den Hobson Prior anbietet, wenden Sie sich bitte an unser Team: E-Mail: firstname.lastname@example.org Telefon: +41 (0) 615880991
View Press Release Hobson Prior secures SECO labour license for Swiss interim recruitment Hobson Prior is pleased to have qualified for a SECO labour licence for interim recruitment. This will enable them to provide the Swiss life sciences industry with interim recruitment solutions, without the need for third-party payrolling companies. Already holding a SECO recruitment license for permanent positions, Hobson Prior will be able to provide full-service recruitment solutions and wider candidates support for life sciences companies and job seekers within Switzerland. Having recently moved their Switzerland based office from Luzern to Basel in 2019, Hobson Prior has over 10 years’ experience working directly with Swiss-based companies, as well as companies looking to launch in Switzerland, with their hiring needs. “By directly providing employed solutions for temporary workers, our clients have a simpler, single contact process for their interim workforce,” comments Patrick Forster, Managing Director of Hobson Prior. “Switzerland is a crucial hub in the global life sciences market and as one of the few specialists’ recruiters focused on life sciences, we’re excited to be able to provide even better recruitment solutions to our clients and better support to our Swiss-based interim workers”. Recognised as number one for global talent competitiveness, innovation and site selection by KPMG, Switzerland stands as one of the leading homes for biotechnology, medical devices, nanotechnology and pharma. “We have a dedicated team specialising in Swiss life sciences recruitment services, covering various aspects of the sector, including regulatory affairs, clinical operations, biometrics and technical operations,” adds European Client Services Manager James Inwood. “These consultants know the Swiss market, customs and recruitment processes. With recruitment consultants based in our Swiss office, we can provide dedicated support not only to our Swiss clients, but to candidates and companies looking to expand into the Swiss biotech and pharmaceutical markets.” “Switzerland is home to many ground-breaking companies and this new licence empowers us to connect them to our extensive network of talented life sciences professionals within commuting distance of their Swiss offices and even help with relocation support for those looking to move to Switzerland.” Switzerland is already home to major pharmaceutical companies and biotechnology innovators; it is no wonder there has been an increase in niche start up businesses driven from places such as the US market to make Switzerland a leading hub for global life sciences development and delivery. As experienced leaders within the Swiss life sciences recruitment market, Hobson Prior has been providing exceptional search and selection support to global leaders and upcoming businesses for over 12 years within Switzerland. This new license will empower them to continue to support the ground-breaking effort of pharma, biotech and med tech companies within Switzerland through expert recruitment services. For more information about Hobson Prior’s SECO license or Swiss recruitment solutions, please contact our Swiss team here:Email: email@example.com Telephone: +41 (0) 615880991
Taking calculated risks has led to some of the ground-breaking developments within biotechnology, particularly amongst younger businesses. From bringing a new orphan to market, to delivering solutions that reduce suffering for patients; the growing rise in emerging biotechnology solutions is transforming healthcare and the life sciences industry. Despite making waves across the industry, many of the merging biotechnology companies that come to us highlight the difficulty they have in securing quality candidates. With investors needing timely results and budgets often tight, having qualified employees on the team is key, but how can these lesser-known companies compete with the global pharmaceutical and biotechnology companies that are also vying for exceptional candidates? What motivates life scientist to take a job? To attract the best talent within the industry, it is important to understand what encourages life sciences professionals to take a new job. We asked over 1,280 life sciences professionals what was their key motivator for changing job, and the top three results were: Career progression (24%) Flexibility and work-life balance (23%) Ability to work on an exciting project (23%) Interestingly, only 2% ranked company reputation as their main motivator in selecting a new job, suggesting the focus appears to be more on career opportunity and the vision of the company, rather than the infancy of the business itself. Now if this were truly the case, lesser-known enterprising biotechnology companies wouldn’t struggle to compete for top talent against established, internationally renowned biopharma. Ultimately, numerous factors, beyond company reputation, encourage professionals to work a for a company, but it is promising to see that size and infancy of the company are have less influence than may be expected. Competing as a smaller biotechnology company The biotechnology industry is continuing to grow. As greater investment and improved accessibility to resources evolves, more advancements and breakthroughs keeps small, independent and start-up biotechnology companies in competition with big pharma. Talented life sciences professionals are regularly headhunted by global pharma companies and rarely stay out of a job for long. There are numerous reasons for candidates to consider joining a smaller company at a junior or senior level: Greater exposure to processes Exciting projects to work in a ground-breaking industry sector Potential fast-track to leadership positions A more targeted benefits package relevant to their lifestyle More flexible working hours and less rigid internal policies Potential investment of shares Despite these exciting career opportunities, there are still roadblocks making it more difficult for a smaller company to attract experienced and skilled candidates: Vacancy Visibility Limited budget and minimal experience hiring within the life sciences industry can make it difficult for start-up and small biotechnology businesses to promote their vacancies. Even with a competitive salary and desirable career development opportunities, if the job advertisement is not visible to the relevant candidates, it is unlikely to draw in applications. The biotechnology employment market is seeing a greater demand for professionals with niche specialist knowledge. Often these skillsets are limited and without the ability to promote vacancies to a broader audience, particularly on an international level, this creates a higher risk for frustrating and costly hiring delays. Resources Without an established internal talent acquisition or dedicated HR function, the role of hiring within smaller businesses can often fall onto senior leadership. This can be problematic in the early stages of a company’s development as these leaders’ time is sparse. Even with a dedicated team to aid in internal recruitment, smaller companies are short on budget, time and will be unlikely to have the same resources available at a blue-chip pharmaceutical company to attract top talent. Without candidate sourcing tools, headhunting processes and an interview planning and execution process, hiring can become a tedious and draining project, alongside the various other important tasks of establishing a new lab and developing new business. Reputation Despite only 2% listing it as their main motivation, it is naive to assume that candidates will not be interested in previous success and the future stability of their prospective new employer. Arguably less of a prominent issue within the contract employment market, professionals looking to move into their next permanent position will be cautious of moving to a company they may not have heard of before. The best candidates that will bring efficiency and innovation to a small company are likely also being headhunted and offered positions at businesses with extensive teams, proven history of development and a global reputation. It can be very intimidating trying to source candidates against such competition, especially when resources and visibility are limited. Attracting the top talent Although some candidates may consider a small business or start-up as a risky move in their career, a smaller, less established brand allows for many opportunities to grow in a role and take a lead on projects. There are various ways in which leaders in small biotechs can attract top talent to consider joining their teams. Networking The adage still stands true today; “it’s not necessarily what you know, but who you know”. Attending corporate events is a useful way to engage more in the industry as well as widen your network of professional contacts. Talented professionals tend to know other talented professionals so the wider your network, the greater your chance of business and vacancies being communicated to relevant and skilled people. Social forums such as LinkedIn can be a useful way to engage with industry professionals and builds international bridges across the sector. A few moments a day contributing to discussions within groups, expanding your networking and communicating with relevant professionals can have a large impact. Outsource your recruitment If time resources are limited, it is worth looking into utilising a recruitment agency to remove the pressure of sourcing candidates, arranging interviews and managing candidate feedback and communication. A recruitment agency will also enable you to quickly and effectively widen the scope of your candidate search, with pre-built, global networks of experienced life sciences professionals. Working on your behalf, they will engage the industry and ensure that you have access to a diverse selection of talented and skilled individuals who can bring value to your business. Clear career development progression, company benefits and flexible working, achievements and goals for the company’s future, a strong and inspiring mission statement; all of these can help your small business stand out against larger pharmaceutical companies, where company culture and employee value can be difficult to demonstrate or more rigid. However your small business operates, highlighting your forward-thinking and unique company culture is a great advantage, particularly when engaging candidates who are fed up with some of the difficulties and restrictions of working as part of a global enterprise. Size doesn't matter There are numerous advantages in joining a smaller team, including more influence and experience, faster access to leadership roles and potentially greater flexibility to offer better working benefits. Understanding and actively promoting the benefits of your business and its culture, you are in a much stronger position to attract top talent. We work closely with our clients to ensure that the candidates in the interview process are aware of the numerous benefits of company life as well as the opportunity within the role. It can be difficult to compete for talented scientists and specialists against globally established businesses. Often, the issue is not convincing candidates in taking the risk to join a newer or smaller company, but rather, getting access to them in the first place. By outsourcing recruitment and continuing to network within the industry, your reputation and visibility will continue to expand, allowing your headhunting efforts and headcount to grow as your business continues to develop and establish itself within the market.